MOTS-c
Aimed at metabolism and exercise performance. A mitochondrial-derived peptide that targets metabolic flexibility, insulin sensitivity, and exercise response.
MOTS-c: Aimed at metabolism and exercise performance. A mitochondrial-derived peptide that targets metabolic flexibility, insulin sensitivity, and exercise response. MOTS-c is a tiny peptide your mitochondria make.
MOTS-c is a tiny peptide your mitochondria make. It's tied to insulin sensitivity and metabolic flexibility. Used as a metabolic support tool during cuts or when fasting tolerance is low.
Mitochondrial-derived peptide. Naturally produced, but exogenous use is a different question.
Recommended by FDA's advisory committee on July 23, 2026, against the recommendation of FDA's review staff. The vote is advisory, does not bind FDA, and no rulemaking has followed.
Prohibited under S4.4.1 (AMPK activators) within S4 Metabolic Modulators, banned at all times. WADA names AMPK activators directly, and MOTS-c is an AMPK activator.
Not prescribed in conventional medicine.
Who it's for
- →Users on a cut wanting metabolic support
- →People with insulin-resistance markers
- →Endurance athletes
What to expect
- Week 1
Subtle. Some report better fasted training tolerance.
- Week 4
Body comp shifts in users running it alongside a cut.
- Week 8
Plateau. Take a break.
Looking at MOTS-c? Your next 3 steps
- 1Work out your syringe units
Vial size + BAC water turns into the exact units to draw for MOTS-c.
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account gets you Coach questions every day, free; membership saves your stack and makes the Coach stack-aware.
Create free account →
How it works (mechanism)
Mitochondrial-derived peptide encoded inside the 12S rRNA region. Activates AMPK signaling (the metabolic 'energy sensor') and improves insulin sensitivity in skeletal muscle.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Active malignancy
- ⚠Pregnancy / nursing
Bloodwork to monitor
- • Fasting glucose / insulin baseline + week 6
Common mistakes
- • Running it without a clean diet (effects get masked)
- • Skipping the cycle break
What it actually is
MOTS-c is a short peptide encoded not by your nuclear DNA but by your mitochondrial DNA — one of a small family of mitochondrial-derived peptides discovered in the last fifteen years. That origin is genuinely novel biology rather than a marketing angle. It is not FDA-approved, and the human evidence is thinner than a record count suggests: FDA's 2026 review found no clinical studies in which MOTS-c was actually administered to people, and no human pharmacokinetic or safety data by any route. The indexed human records observe the body's own MOTS-c levels; they are not treatment trials.
In cell and animal work MOTS-c appears to act as a metabolic stress signal: it interferes with the folate cycle in a way that activates AMPK, the enzyme cells use to sense low energy and switch toward burning fuel rather than storing it. In animals that improves insulin sensitivity and protects against diet-induced obesity. The account is preclinical — FDA concluded its molecular targets, dose-response and human pharmacokinetics are unknown. The observational picture is also more mixed than usually stated: circulating levels are lower in older people while skeletal-muscle levels are higher, and the exercise rise comes from a small acute study in ten young men.
Forms, and which is which
Buyer reconstitutes. Research-chemical supply, no identity or purity assurance.
Verdict: The only form, fully unregulated.
Peptides are less stable in solution than as a dried powder. Neither form can be authenticated by looking at it — identity, strength, purity, endotoxin and sterility need analytical testing.
Verdict: No format of an unverified product is the verified one.
Worth separating: SS-31 (elamipretide) is FDA-approved for Barth syndrome and does have human clinical evidence, while humanin and MOTS-c do not. Blending them makes anything observed unattributable and lends the approved compound's credibility to the others.
Verdict: One approved compound diluted into unknowns.
Not absorbed intact from the gut at this size.
Verdict: Not plausible by the route claimed.
What it is claimed to do, graded
Well demonstrated in mice, including the original 2015 Cell Metab paper. No completed trial has administered MOTS-c to people, so nothing establishes this in humans.
Shown in mice. No human trial demonstrates weight or fat loss.
The exercise-mimetic framing is based on the observation that MOTS-c rises with exercise, which is not the same as showing that giving it improves performance.
No human data of any kind. The mouse work is on healthspan markers, not human longevity.
A 2024 paper reports suppression of ovarian cancer progression in a model system. Model-system work, and it should not be read as a reason to take it or a reassurance about cancer risk.
Grades describe how much human evidence exists for that specific claim, not whether it will work for you or whether it is safe.
Pros and cons
- • Genuinely novel biology — a mitochondrially encoded peptide is a real discovery, not a rebranded old compound
- • The AMPK mechanism is well characterised and connects to a large, respectable metabolic literature
- • Animal data is consistent across several models
- • Reported side effects at commonly used amounts are mild
- • No completed trial has administered it to a person — the indexed human records observe the body's own levels
- • The exercise-mimetic framing is marketing running ahead of evidence
- • Not FDA-approved, and FDA staff recommended against adding it to the 503A bulk-drug list in 2026
- • Sold as a research chemical with unverified identity — which is not the same as unregulated, since a product offered for human use is an unapproved drug
- • Doses used by consumers are extrapolated from animal work, not derived from human studies
When to stop
- • Hypoglycaemic symptoms, especially if you take glucose-lowering medication
- • Persistent fatigue beyond the first week
- • Injection-site reaction that spreads
- • Any new cancer diagnosis
Interactions
Both act on AMPK signalling. Redundant mechanism, and combined effects on glucose are unstudied.
If it does improve insulin sensitivity, it works in the same direction, so glucose can go lower than intended.
Stacking compounds with no human evidence makes any effect or side effect unattributable.
Not an interaction. Exercise is the intervention with actual evidence for everything MOTS-c is taken for.
Metabolic reprogramming in a body with a tumour is unstudied in either direction.
Is this for you?
- • People who find the mitochondrial-peptide biology interesting and understand they are ahead of the evidence
- • Anyone tracking fasting glucose and insulin so the claim can actually be checked
- • You have active cancer
- • You are pregnant or nursing
- • You are on glucose-lowering medication without a way to monitor
- • You want an exercise substitute — that is the claim with the least behind it
The one number
Sources for the claims above
- Promotes metabolic homeostasis and reduces obesity and insulin resistance in mice
- Review of therapeutic potential
- Relieves hyperglycaemia and insulin resistance in gestational diabetes models
Community patterns
New to MOTS-c? Grab the starter checklist.
Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.
No spam, and we never sell your email. Just the checklist. Email support@pepdex.co to opt out any time.
Numbers redacted in this preview. Members get the full answer, on their own stack.
Ask the Coach anything about MOTS-c or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Unlock the full Coach, from $4.99/week →Frequently asked
What is MOTS-c?+
Is MOTS-c FDA approved?+
Is MOTS-c legal?+
Is MOTS-c banned by WADA?+
Are you still natty after taking MOTS-c?+
Do doctors prescribe MOTS-c?+
What's the typical dose of MOTS-c?+
What are the side effects of MOTS-c?+
How long until MOTS-c starts working?+
What can you stack with MOTS-c?+
Where do people get MOTS-c?+
MOTS-c vs 5-Amino-1MQ, which is better?+
Common questions about MOTS-c
Head-to-head with MOTS-c
Tracked alongside MOTS-c
Same goal, different aisle — each graded on its own evidence in the Pepdex catalog.
More in Metabolic
Used clinically to boost fertility and restart the body's own testosterone production after a suppressive cycle. It's a glycoprotein hormone that works by mimicking LH at the testicular Leydig cell.
Boosts your cells' energy production at the source. A mitochondria-targeting peptide that concentrates in the inner mitochondrial membrane to support ATP production, FDA-approved in 2025 as FORZINITY for Barth syndrome, the first mitochondria-targeted drug, with all other uses off-label.